ESR1 and breast carcinoma: The MCF-7 line is a well-characterized estrogen-receptor-positive model of breast cancer—the leading malignant tumor affecting women globally, with an estimated 2.3 million new diagnoses and 630,000 deaths per year across 185 countries [95].